While at the American Health Law Association’s 2026 Health Care Transactions Conference in Nashville last week, the Levin Associates team asked several attendees what they view as the biggest regulatory hurdles in healthcare transactions right now in 2026. Attendees highlighted the rising challenges from proliferating state transaction review laws and heightened fraud and abuse enforcement. Watch the video below to hear what they had to say.
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
